NCT06827769View on ClinicalTrials.gov

Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

January 30, 2025

Study Completion Date

February 1, 2025

Conditions

Chronic Liver Disease and Cirrhosis

Interventions

DIAGNOSTIC_TEST

serum zinc and magnesium

participants will be subjected to laboratory investigations (complete blood picture, liver and kidney function tests, Prothrombin time, international normalized ratio (INR), serum zinc, and magnesium).

Trial Locations (1)

31516

Tanta University Hospitals, Tanta

All Listed Sponsors

lead

Tanta University

OTHER

NCT06827769 - Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients | Biotech Hunter | Biotech Hunter